Evidence is mounting that GLP-1 drugs may play a role in reducing cancer risk and deaths from certain cancers.
Prognostic Models From Transcriptomic Signatures of the Tumor Microenvironment and Cell Cycle in Stage III Colon Cancer From PETACC-8 and IDEA-France Trials In this pilot study, we assessed the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results